is one of the main causative agents of nosocomial infections and the spread of multidrug-resistant strains is rising. Therefore， novel strategies for therapy are urgently required. The outer membrane composition of Gram-negative pathogens and especially of restricts the efficacy of antibiotic entry into the cell and determines virulence. For efficient outer membrane protein biogenesis， the β-barrel assembly machinery (BAM) complex in the outer membrane and periplasmic chaperones like Skp and SurA are crucial. Previous studies indicated that the importance of individual proteins involved in outer membrane protein biogenesis may vary between different Gram-negative species. In addition， since multidrug-re... More
is one of the main causative agents of nosocomial infections and the spread of multidrug-resistant strains is rising. Therefore， novel strategies for therapy are urgently required. The outer membrane composition of Gram-negative pathogens and especially of restricts the efficacy of antibiotic entry into the cell and determines virulence. For efficient outer membrane protein biogenesis， the β-barrel assembly machinery (BAM) complex in the outer membrane and periplasmic chaperones like Skp and SurA are crucial. Previous studies indicated that the importance of individual proteins involved in outer membrane protein biogenesis may vary between different Gram-negative species. In addition， since multidrug-resistant strains pose a serious global threat， the interference with both virulence and antibiotic resistance by disturbing outer membrane protein biogenesis might be a new strategy to cope with this challenge. Therefore， deletion mutants of the non-essential BAM complex components and ， of the homolog as well as a conditional mutant of were investigated. The most profound effects for both traits were associated with reduced levels of SurA， characterized by increased membrane permeability， enhanced sensitivity to antibiotic treatment and attenuation of virulence in a infection model. Strikingly， the depletion of SurA in a multidrug-resistant clinical bloodstream isolate re-sensitized the strain to antibiotic treatment. From our data we conclude that SurA of serves as a promising target for developing a drug that shows antiinfective activity and re-sensitizes multidrug-resistant strains to antibiotics.
